Sagimet Biosciences Inc. (SGMT)
NASDAQ · Healthcare
Sagimet Biosciences Inc. Operating Income 2023–2023
Sagimet Biosciences Inc. annual/quarterly operating income history and growth rate from 2023 to 2023. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Sagimet Biosciences Inc. operating income for the quarter ending September 30, 2023 was -7.5 M.
- Sagimet Biosciences Inc. annual operating income for 2023 was -30.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sagimet Biosciences Inc. Operating Income — FAQ
Sagimet Biosciences Inc. (SGMT) operating income over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
What is Sagimet Biosciences Inc.'s operating income?
Sagimet Biosciences Inc. (SGMT) reported operating income of -$31M for fiscal 2023.
Where can I see SGMT's operating income history?
The chart and table above show Sagimet Biosciences Inc.'s operating income by year and by quarter, including the growth rate.